Workup for Isolated Elevated Transaminases
For isolated elevated ALT and/or AST with normal bilirubin, alkaline phosphatase, albumin, PT/INR, and platelets, perform a standard liver aetiology screen regardless of the degree of elevation, as the extent of abnormality does not determine clinical significance 1.
Initial Diagnostic Approach
The British Society of Gastroenterology guideline is clear: any abnormal liver test result (outside laboratory reference range) warrants investigation with a liver aetiology screen, irrespective of level and duration of abnormality 1. This is critical because even mild elevations can represent significant underlying disease.
Standard Liver Aetiology Screen Should Include:
- Abdominal ultrasound
- Hepatitis B surface antigen
- Hepatitis C antibody (with PCR if positive)
- Anti-mitochondrial antibody
- Anti-smooth muscle antibody
- Antinuclear antibody
- Serum immunoglobulins
- Simultaneous serum ferritin and transferrin saturation 1
Additionally, assess for metabolic syndrome components: waist circumference, blood pressure, fasting lipids, and fasting glucose or A1C 2.
Algorithmic Evaluation by Most Common Causes
The most common causes of isolated transaminase elevation are nonalcoholic fatty liver disease (NAFLD) and alcoholic liver disease, accounting for the majority of cases 2. Your evaluation should prioritize these first.
Primary Considerations:
- NAFLD/Metabolic Syndrome: Look for BMI >25, diabetes, hypertension, dyslipidemia
- Alcohol use: Obtain detailed alcohol history (AST:ALT ratio >2 suggests alcoholic liver disease; <1 suggests NAFLD) 2
- Medications: Review all prescribed and over-the-counter medications for drug-induced liver injury 3
Secondary Considerations (if initial screen negative):
- Hereditary hemochromatosis (ferritin/transferrin saturation already ordered)
- Autoimmune hepatitis (autoantibodies already ordered)
- Wilson disease (in patients <40 years, add ceruloplasmin)
- Alpha-1 antitrypsin deficiency (add A1AT level) 2, 3
Critical Pitfall: Extrahepatic Causes
Do not assume liver origin without excluding muscle disorders, particularly if AST is elevated disproportionately to ALT. Check creatine phosphokinase (CK) to rule out muscle disease, especially in pediatric patients 4. Other extrahepatic causes include:
- Thyroid disorders (check TSH)
- Celiac disease (check tissue transglutaminase antibodies)
- Hemolysis (review CBC already ordered) 2
Risk Stratification for NAFLD
If the workup suggests NAFLD (metabolic risk factors present, negative viral/autoimmune/genetic testing, ultrasound showing steatosis), you must perform fibrosis risk stratification using FIB-4 or NAFLD Fibrosis Score (NFS) 1. This determines whether the patient needs specialist referral:
- Low-risk scores: Trial of lifestyle modification with repeat assessment
- Indeterminate or high-risk scores: Refer to hepatology for further evaluation and possible elastography 1
When to Refer
Refer to hepatology if:
- Fibrosis scores are indeterminate or high-risk
- Diagnosis remains unclear after standard aetiology screen
- Transaminases remain elevated >6 months despite lifestyle modification
- AST remains above normal or ALT >2× upper limit of normal after 6 months 4
Management Based on Findings
If NAFLD is confirmed and fibrosis risk is low: Implement lifestyle modification (weight loss of 7-10%, exercise, dietary changes) and monitor transaminases every 3-6 months 2. Note that approximately 30% of elevated transaminases normalize spontaneously during follow-up 5.
If specific etiology identified (viral hepatitis, hemochromatosis, autoimmune hepatitis, Wilson disease): Initiate disease-specific treatment or refer appropriately 3.
The guideline emphasizes that abnormal results should only be interpreted after reviewing previous results, past medical history, and current medical condition 1—isolated values without context can be misleading.